Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kineret in macrophage activation syndrome
NCT02780583Phase 1Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2016
- Primary completion
- Mar 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of anakinra in macrophage activation syndrome (MAS), sponsored by University of Alabama at Birmingham. Started May 2016; status: terminated.
02
Drugs
anakinra
03
Conditions
macrophage activation syndrome (MAS)
Beyond the preview
Go deeper on NCT02780583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02780583.